DDInter948 DDInter75
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
An antitubercular agent often administered in association with isoniazid. The sodium salt of the drug is better tolerated than the free acid.
Aminosalicylic acid {u} (Compound) resembles {v} (Compound) Levodopa
Aminosalicylic acid {u} (Compound) resembles {v} (Compound) Droxidopa
Aminosalicylic acid {u} (Compound) binds {v} (Gene) ALOX5
Aminosalicylic acid {u} (Compound) upregulates {v} (Gene) NFKB2
Aminosalicylic acid {u} (Compound) downregulates {v} (Gene) SNX7
Aminosalicylic acid {u} (Compound) causes {v} (Side Effect) Nervous system disorder
Aminosalicylic acid {u} (Compound) binds {v} (Gene) and {u} (Compound) upregulates {v} (Gene) PTGS2
Aminosalicylic acid (Compound) resembles Levodopa (Compound)
Aminosalicylic acid (Compound) resembles Droxidopa (Compound)
Aminosalicylic acid (Compound) binds ALOX5 (Gene)
Aminosalicylic acid (Compound) upregulates NFKB2 (Gene)
Aminosalicylic acid (Compound) downregulates SNX7 (Gene)
Aminosalicylic acid (Compound) causes Nervous system disorder (Side Effect)
Aminosalicylic acid (Compound) binds PTGS2 (Gene) and Aminosalicylic acid (Compound) upregulates PTGS2 (Gene)